Drs. Parekattil, Galante Named Among Top Physicians for Second Consecutive Year

In the recently published August issue of Orlando Family Magazine, Dr. Sijo Parekattil, Medical Director, and Dr. Alex Galante, Partner, of Avant Concierge Urology were named among the publication’s list of Top Physicians for 2022. This is the second time in as many years since Avant Concierge Urology opened that the practice has been named to the prestigious list.

According to the magazine, “…Each year we like to celebrate these selfless individuals for the trusted care they provide and the manner in which they do so. Our Top Physicians list—as chosen by their peers and our readers—features some of the foremost doctors you’ll find in Central Florida and advancements in medicine have only strengthened their capabilities to keep us healthy and happy.”

Avant Concierge Urology was recognized as a leader among medical practices in the region. With the goal of reduced downtime and increased outcomes, Avant Concierge Urology offers the latest and most advanced technologies to treat patients seeking best-in-class medical expertise in the areas of: 

To read the August 2022 issue of Orlando Family Magazine, click here.

2022 has already been an exciting year for Avant Concierge Urology. In June, Avant Concierge Urology made global history as the first doctor’s office to join the clinical trial for the ProVee System, a nitinol expander designed to gently re-shape the enlarged prostate and alleviate the symptoms caused by BPH. At that time, Dr. Parekattil successfully performed the first procedure for the clinical trial in his Central Florida-based office. ProVee is a ‘stent-like’ expander designed to gently open up the obstructed urethra without heating, piercing, cutting, or removing part of the prostate. The delivery system for the expander is thinner than most currently available BPH treatment options, and the uncomplicated procedure is intended to be performed in an outpatient or doctor’s office setting. Click here to learn more about the clinical trial.

Leave a Reply

Your email address will not be published. Required fields are marked *